These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7135352)

  • 1. Detection of hypercoagulability by the measurement of the dynamic loss modulus of clotting blood.
    Sugiura K; Ikeda Y; Ono F; Watanabe K; Ando Y
    Thromb Res; 1982 Jul; 27(2):161-6. PubMed ID: 7135352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity and postoperative deep-vein thrombosis.
    Fossard DP; Friend JR; Field ES; Corrigan TP; Kakkar VV; Flute PT
    Lancet; 1974 Jan; 1(7845):9-11. PubMed ID: 4129028
    [No Abstract]   [Full Text] [Related]  

  • 3. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis.
    Spiezia L; Marchioro P; Radu C; Rossetto V; Tognin G; Monica C; Salmaso L; Simioni P
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):355-60. PubMed ID: 18600082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.
    Llach F
    Kidney Int; 1985 Sep; 28(3):429-39. PubMed ID: 3906225
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory testing for hypercoagulable disorders.
    Jones MP; Alving B
    Curr Opin Hematol; 1996 Sep; 3(5):365-71. PubMed ID: 9372103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of hemostasis in patients with myocardial infarction complicated by deep venous thrombosis].
    Lewandowski K; Psuja P; Zozulińska M; Turowiecka Z; Zawilska K
    Pol Arch Med Wewn; 1990 Aug; 84(2):79-85. PubMed ID: 2277786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Types of AT III abnormalities and their significance in hypercoagulability.
    Nagy I; Losonczy H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):421-5. PubMed ID: 6083906
    [No Abstract]   [Full Text] [Related]  

  • 9. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
    Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
    Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorheological alterations and hypercoagulable state in deep vein thrombosis.
    Mira Y; Vayá A; Martínez M; Villa P; Santaolaria ML; Ferrando F; Aznar J
    Clin Hemorheol Microcirc; 1998 Dec; 19(4):265-70. PubMed ID: 9972663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposition to thrombosis not reflected by the blood coagulogram.
    Solymoss B; Selye H; Gabbiani G
    J Clin Pathol; 1966 Jul; 19(4):331-3. PubMed ID: 5929333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attempt at predicting postoperative deep vein thrombosis by preoperative coagulation studies in patients undergoing total hip replacement.
    Nilsen DW; Jeremic M; Weisert OK
    Thromb Haemost; 1980 Jul; 43(3):194-7. PubMed ID: 6779397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercoagulable states.
    Rogers JS
    W V Med J; 1993 Feb; 89(2):61-3. PubMed ID: 8442350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulability in venous and arterial thrombosis.
    Thomas DP; Roberts HR
    Ann Intern Med; 1997 Apr; 126(8):638-44. PubMed ID: 9103132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hypercoagulability in thrombosis.
    Stewart GJ
    Br J Haematol; 1978 Nov; 40(3):359-62. PubMed ID: 373790
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism.
    van Hulsteijn H; Bertina R; Briët E
    Thromb Res; 1982 Jul; 27(2):225-9. PubMed ID: 6182625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.